Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Arch Pathol Lab Med Retrieve available abstracts of 41 articles: HTML format

Single Articles

February 2021
1. TERRA SBSP, Roden AC, Aubry MC, Yi ESJ, et al
   Utility of Immunohistochemistry for MUC4 and GATA3 to Aid in the Distinction of Pleural Sarcomatoid Mesothelioma From Pulmonary Sarcomatoid Carcinoma.
   Arch Pathol Lab Med. 2021;145:208-213.
   PubMed     Abstract available
   
   
   January 2021
2. NAMBIRAJAN A, Singh V, Bhardwaj N, Mittal S, et al
   SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
   Arch Pathol Lab Med. 2021;145:90-98.
   PubMed     Abstract available
   
   
   September 2020
3. STAAF J, Tran L, Soderlund L, Nodin B, et al
   Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
   Arch Pathol Lab Med. 2020;144:1075-1085.
   PubMed     Abstract available
   
   
   June 2020
4. HUANG RSP, Smith D, Le CH, Liu WW, et al
   Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization.
   Arch Pathol Lab Med. 2020;144:735-741.
   PubMed     Abstract available
   
   
   May 2020
5. IBRAHIM A, Chopra S
   Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
   Arch Pathol Lab Med. 2020;144:655-660.
   PubMed     Abstract available
   
   
   April 2020
6. REKHTMAN N
   "Napoleon Hat" Sign: A Distinctive Cytologic Clue to Reactive Pneumocytes.
   Arch Pathol Lab Med. 2020;144:443-445.
   PubMed     Abstract available
   
   
   
7. LE STANG N, Burke L, Blaizot G, Gibbs AR, et al
   Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
   Arch Pathol Lab Med. 2020;144:446-456.
   PubMed     Abstract available
   
   
   March 2020
8. PARRA ER, Jiang M, Machado-Rugolo J, Yaegashi LB, et al
   Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer.
   Arch Pathol Lab Med. 2020 Mar 9. doi: 10.5858/arpa.2019-0419.
   PubMed     Abstract available
   
   
   
9. COZZOLINO I, Ronchi A, Messina G, Montella M, et al
   Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous
   Arch Pathol Lab Med. 2020;144:361-369.
   PubMed     Abstract available
   
   
   February 2020
10. DERAKHSHAN F, Ionescu D, Cheung S, Churg A, et al
    Use of Programmed Death Ligand-1 (PD-L1) Staining to Separate Sarcomatoid Malignant Mesotheliomas From Benign Mesothelial Reactions.
    Arch Pathol Lab Med. 2020;144:185-188.
    PubMed     Abstract available
    
    
    January 2020
11. NIZAMADDIN SK, Mehrotra M, Nadhim ASH, Luthra R, et al
    Detection of EGFR T790M Mutation by Droplet Digital Polymerase Chain Reaction in Lung Carcinoma Cytology Samples.
    Arch Pathol Lab Med. 2020 Jan 6. doi: 10.5858/arpa.2019-0411.
    PubMed     Abstract available
    
    
    May 2019
12. LAYFIELD LJ, Hammer RD, White SK, Furtado LV, et al
    Molecular Testing Strategies for Pulmonary Adenocarcinoma: An Optimal Approach With Cost Analysis.
    Arch Pathol Lab Med. 2019;143:628-633.
    PubMed     Abstract available
    
    
    April 2019
13. HUANG RSP, Holmes BF, Powell C, Marati RV, et al
    Delta-like Protein 3 Prevalence in Small Cell Lung Cancer and DLL3 (SP347) Assay Characteristics.
    Arch Pathol Lab Med. 2019 Apr 8. doi: 10.5858/arpa.2018-0497.
    PubMed     Abstract available
    
    
    January 2019
14. LU YW, Yeh YC
    Ciliated Muconodular Papillary Tumors of the Lung.
    Arch Pathol Lab Med. 2019;143:135-139.
    PubMed     Abstract available
    
    
    December 2018
15. LAMBROS L, Uguen A
    NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?
    Arch Pathol Lab Med. 2018;142:1451-1452.
    PubMed    
    
    
    November 2018
16. TROSCHEL FM, Gottumukkala RV, DiCorpo D, Mario J, et al
    Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.
    Arch Pathol Lab Med. 2018 Nov 20. doi: 10.5858/arpa.2018-0249.
    PubMed     Abstract available
    
    
    October 2018
17. THUNNISSEN E
    How to Validate Predictive Immunohistochemistry Testing in Pathology?: A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer.
    Arch Pathol Lab Med. 2018 Oct 11. doi: 10.5858/arpa.2018-0410.
    PubMed    
    
    
    August 2018
18. AKALIN A, Ergin A, Remiszewski S, Mu X, et al
    Resolving Interobserver Discrepancies in Lung Cancer Diagnoses by Spectral Histopathology.
    Arch Pathol Lab Med. 2018 Aug 24. doi: 10.5858/arpa.2017-0476.
    PubMed     Abstract available
    
    
    
19. BORCZUK AC
    Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma.
    Arch Pathol Lab Med. 2018;142:914-921.
    PubMed     Abstract available
    
    
    July 2018
20. BORCZUK AC
    Keeping Up With Testing Guidelines in Lung Cancer.
    Arch Pathol Lab Med. 2018;142:783-784.
    PubMed    
    
    
    June 2018
21. LUK PP, Selinger CI, Mahar A, Cooper WA, et al
    Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.
    Arch Pathol Lab Med. 2018 Jun 14. doi: 10.5858/arpa.2017-0502.
    PubMed     Abstract available
    
    
    April 2018
22. SAXENA A
    Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients with Targetable Mutations Following Disease Progression.
    Arch Pathol Lab Med. 2018 Apr 12. doi: 10.5858/arpa.2018-0111.
    PubMed    
    
    
    
23. PLANCHARD D, Johnson BE
    BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.
    Arch Pathol Lab Med. 2018 Apr 12. doi: 10.5858/arpa.2018-0088.
    PubMed    
    
    
    
24. HALMOS B
    Molecular Testing in Lung Cancer: Where to Draw the Line?
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0060.
    PubMed    
    
    
    
25. ALTORKI NK
    Molecular Testing for Early Lung Cancer.
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0087.
    PubMed    
    
    
    
26. GUERINI-ROCCO E, Passaro A, Casadio C, De Luca VM, et al
    Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.
    Arch Pathol Lab Med. 2018;142:465-473.
    PubMed     Abstract available
    
    
    
27. ALI G, Bruno R, Savino M, Giannini R, et al
    Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?
    Arch Pathol Lab Med. 2018;142:480-489.
    PubMed     Abstract available
    
    
    March 2018
28. AISNER DL
    The Revised College of American Pathologists/International Association for the Study of Lung Cancer Guidelines/Association for Molecular Pathology: A Step Forward for Molecular Cytopathology.
    Arch Pathol Lab Med. 2018 Mar 29. doi: 10.5858/arpa.2018-0081.
    PubMed    
    
    
    
29. JAIN D, Roy-Chowdhuri S
    Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
    Arch Pathol Lab Med. 2018 Mar 16. doi: 10.5858/arpa.2017-0444.
    PubMed     Abstract available
    
    
    
30. LOZANO MD, Echeveste JI, Abengozar M, Mejias LD, et al
    Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
    Arch Pathol Lab Med. 2018;142:291-298.
    PubMed     Abstract available
    
    
    February 2018
31. DEL C MONROIG-BOSQUE P, Driver B, Morales-Rosado JA, Deavers M, et al
    Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.
    Arch Pathol Lab Med. 2018 Feb 12. doi: 10.5858/arpa.2017-0516.
    PubMed     Abstract available
    
    
    January 2018
32. DOXTADER EE, Cheng YW, Zhang Y
    Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration.
    Arch Pathol Lab Med. 2018 Jan 26. doi: 10.5858/arpa.2017-0184.
    PubMed     Abstract available
    
    
    
33. LINDEMAN NI, Cagle PT, Aisner DL, Arcila ME, et al
    Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and
    Arch Pathol Lab Med. 2018 Jan 22. doi: 10.5858/arpa.2017-0388.
    PubMed     Abstract available
    
    
    
34. WALTS AE, Marchevsky AM
    Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces.
    Arch Pathol Lab Med. 2018;142:59-63.
    PubMed     Abstract available
    
    
    
35. HUSAIN AN, Colby TV, Ordonez NG, Allen TC, et al
    Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
    Arch Pathol Lab Med. 2018;142:89-108.
    PubMed     Abstract available
    
    
    December 2017
36. MEHRAD M, Roy S, Bittar HT, Dacic S, et al
    Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.
    Arch Pathol Lab Med. 2017 Dec 8. doi: 10.5858/arpa.2017-0046.
    PubMed     Abstract available
    
    
    November 2017
37. DRIVER BR, Miller RA, Miller T, Deavers M, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Arch Pathol Lab Med. 2017;141:1529-1532.
    PubMed     Abstract available
    
    
    September 2017
38. WOO JS, Reddy OL, Koo M, Xiong Y, et al
    Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.
    Arch Pathol Lab Med. 2017;141:1195-1213.
    PubMed     Abstract available
    
    
    August 2017
39. PENG Y, Butt YM, Chen B, Zhang X, et al
    Update on Immunohistochemical Analysis in Breast Lesions.
    Arch Pathol Lab Med. 2017;141:1033-1051.
    PubMed     Abstract available
    
    
    July 2017
40. WANG X, Gao Y, Wang B, Zhang Z, et al
    Analytic and Clinical Validation of an Ultrasensitive, Quantitative Polymerase Chain Reaction Assay for EGFR Mutation Analysis With Circulating Tumor DNA.
    Arch Pathol Lab Med. 2017;141:978-984.
    PubMed     Abstract available
    
    
    June 2017
41. JAIN D, Allen TC, Aisner DL, Beasley MB, et al
    Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
    Arch Pathol Lab Med. 2017 Jun 22. doi: 10.5858/arpa.2017-0114.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: